Activity of rifabutin alone and in combination with clofammine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice
- 1 September 1989
- Vol. 70 (3) , 201-205
- https://doi.org/10.1016/0041-3879(89)90051-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Comparative in vitro and in vivo activity of rifabutin and rifampicin against mycobacterium avium complexTubercle, 1988
- Clofazimine and other rimino-compounds: Minimal inhibitory and minimal bactericidal concentrations at different pHs for mycobacterium avium complexTubercle, 1988
- Activity of Rifabutin Alone or in Combination with Clofazimine or Ethambutol or Both Against Acute and Chronic ExperimentalMycobacterium intracellulareInfectionsAmerican Review of Respiratory Disease, 1987
- Two Groups ofMycobacterium aviumComplex Strains Determined According to the Susceptibility to Rifampicin and AnsamycinMicrobiology and Immunology, 1987
- Rifabutin (Ansamycin LM 427): A New Rifamycin-S Derivative for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1987
- Mycobacteria Other than Mycobacterium tuberculosis: Review of Microbiologic and Clinical AspectsClinical Infectious Diseases, 1987
- Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndromeAntimicrobial Agents and Chemotherapy, 1986
- Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- Treatment of Disease Due to Mycobacterium intracellulareClinical Infectious Diseases, 1981
- Pharmacologic Studies of ClofazimineThe American Journal of Tropical Medicine and Hygiene, 1974